MAPT and Alzheimer disease: In general, current transgenic (tg) AD mouse models are either amyloidosis models, recapitulating only the amyloid β (Aβ) plaque formation from the disease, or tau models, recapitulating only the tau phosphorylation and tangle formation, or multiple tg models combining both pathologies.